相关实验视频

Updated: Jul 11, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

神经免疫学障碍中的介质素-6:病理生理学和Satralizumab的治疗进展

Xicheng Li1, Chongbo Zhao1

  • 1Department of Neurology and Rare Disease Center, Huashan Hospital, Fudan University, Shanghai, China; National Center for Neurological Disorders (NCND), China.

Autoimmunity reviews
|May 5, 2025
PubMed
概括

洲际蛋白-6 (IL-6) 是免疫和炎症中的一个关键细胞因子. 萨特拉利祖马布 (Satralizumab) 是一种IL-6受体抗体,它对治疗神经免疫疾病如NMOSD和gMG有很大的前景.

关键词:
在IL-6的研究中,IL-6被认为是IL-6的基因.在这里,我们可以看到MGMGMGMGMG.这是NMOSD的NMOSD.神经免疫学疾病 神经免疫学疾病这就是Satralizumab.

更多相关视频

Induction of Ocular Surface Inflammation and Collection of Involved Tissues06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

相关概念视频

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
614
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97